Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Internal Medicine (Tokyo, Japan)|September 29, 2024
Clinical Course and Factors Correlated with Severe Morbidity and Mortality in Patients with Coronavirus Disease 2019 Undergoing Maintenance Dialysis in Kanagawa, JapanKohei Ishiga, Hiromichi Wakui, Kengo Azushima, et al.
Scientific Reports|February 14, 2018
Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle TissueKohji Ohki, Hiromichi Wakui, Nozomu Kishio, et al.
Scientific Reports|February 7, 2020
Effects of Rikkunshito treatment on renal fibrosis/inflammation and body weight reduction in a unilateral ureteral obstruction model in miceHiromichi Wakui, Takahiro Yamaji, Kengo Azushima, et al.
Scientific Reports|November 14, 2019
Angiotensin II type 1 receptor-associated protein deficiency attenuates sirtuin1 expression in an immortalised human renal proximal tubule cell lineTakahiro Yamaji, Akio Yamashita, Hiromichi Wakui, et al.
Atherosclerosis|March 31, 2015
Effects of the oriental herbal medicine Bofu-tsusho-san in obesity hypertension: a multicenter, randomized, parallel-group controlled trial (ATH-D-14-01021.R2)Kengo Azushima, Kouichi Tamura, Sona Haku, et al.
BMC Nephrology|September 27, 2025
Effects of sodium zirconium cyclosilicate on the quality of life of patients with hyperkalemia undergoing hemodialysis: Y-QOL study designShiori Yoshimura, Daisuke Kanai, Hiromichi Wakui, et al.
Cardiovascular Diabetology|August 29, 2019
Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study)Sho Kinguchi, Hiromichi Wakui, Yuzuru Ito, et al.
Pageof 4